HMP Global

HMP Global’s Dermatology Division Co-Scientific Director Alice B. Gottlieb, MD, PhD, FAAD, has been elected vice president of the American Academy of Dermatology (AAD), recognizing her leadership in advancing dermatology practice and education. She will be installed as vice president-elect in March 2027 and will serve as vice president beginning March 2028.

Dr. Gottlieb also serves as Co-Chair of the Masterclasses in Dermatology programs, where she helps shape clinical dermatology education designed to improve real-world patient outcomes.

Press release: https://hubs.ly/Q04d0NF00

When evidence points in multiple directions, the most valuable education shows you how to choose.

LL&M Great Debates 2026 will be held June 27–28 in New York City and July 25–26 in Dallas, bringing oncology experts together to examine competing treatment strategies:

- Debate-driven sessions focused on real-world clinical decision making
- Head-to-head perspectives on CAR T, bispecifics, and transplant strategies
- Insight into sequencing and timing of emerging therapies
- Practical guidance for applying data across complex patient scenarios

Press release: https://hubs.ly/Q04cVSVQ0

Explore the full program and why it matters: https://www.hmpglobalevents.com/llmgreatdebates

- For clinicians treating CLTI, staying ahead of evolving techniques and technologies can directly impact whether a limb is saved.

The Amputation Prevention Symposium (AMP) 2026 will be held August 5-8 in a new location in Boston, offering an intensive, multidisciplinary program built around real cases, emerging evidence, and collaborative problem solving.

• Live case presentations that reflect real clinical complexity
• Eight first-to-podium presentations within Session 5 that will include 15 total data talks
• DVA focus, drug-eluting tech, and featuring a cadaver lab

Learn how AMP 2026 is advancing CLTI care: https://hubs.ly/Q04cjZP90

Heading to Digestive Disease Week? Join us for an in-depth look at the evolving role of subcutaneous therapies in inflammatory bowel disease.

HMP Education is hosting a complimentary dinner symposium focused on real-world evidence, patient selection, and practical strategies to optimize outcomes in IBD care. This session brings together leading experts to examine the expanding treatment landscape and share guidance grounded in the latest data.

We are proud to partner with Celltrion in supporting this important educational opportunity.

Faculty include Marla Dubinsky, MD; Anthony Buisson, MD, PhD; Peter Irving, MA, MD, FRCP; and Corey Siegel, MD, MS. Scan the QR on the flyer code to pre-register.

HMP Global’s Dermatology Division Co-Scientific Director Alice B. Gottlieb, MD, PhD, FAAD, has been elected vice president of the American Academy of Dermatology (AAD), recognizing her leadership in advancing dermatology practice and education. She will be installed as vice president-elect in March 2027 and will serve as vice president beginning March 2028.

Dr. Gottlieb also serves as Co-Chair of the Masterclasses in Dermatology programs, where she helps shape clinical dermatology education designed to improve real-world patient outcomes.

Press release: https://hubs.ly/Q04d1sJK0

When evidence points in multiple directions, the most valuable education shows you how to choose.

LL&M Great Debates 2026 will be held June 27–28 in New York City and July 25–26 in Dallas, bringing oncology experts together to examine competing treatment strategies:

- Debate-driven sessions focused on real-world clinical decision making
- Head-to-head perspectives on CAR T, bispecifics, and transplant strategies
- Insight into sequencing and timing of emerging therapies
- Practical guidance for applying data across complex patient scenarios

Press release: https://hubs.ly/Q04cTvXM0

Explore the full program and why it matters: https://www.hmpglobalevents.com/llmgreatdebates

For clinicians treating CLTI, staying ahead of evolving techniques and technologies can directly impact whether a limb is saved.

The Amputation Prevention Symposium (AMP) 2026 will be held August 5-8 in a new location in Boston, offering an intensive, multidisciplinary program built around real cases, emerging evidence, and collaborative problem solving.

• Live case presentations that reflect real clinical complexity
• Eight first-to-podium presentations within Session 5 that will include 15 total data talks
• DVA focus, drug-eluting tech, and featuring a cadaver lab

Learn how AMP 2026 is advancing CLTI care: https://hubs.ly/Q04cjSSY0

Senior living is entering a period of significant growth, and development strategies formed today will shape the future.

The official meeting of Argentum, the 2026 Senior Living Executive Conference, May 18-20 in Nashville, will spotlight how innovation and technology are transforming operations, resident experience, and organizational performance across the industry. Highlights include:

• Leveraging technology to enhance resident experience and efficiency
• Adapting leadership strategy to workforce and market pressures
• Identifying scalable approaches to drive sustainable growth

Press release: https://hubs.ly/Q0475gqH0

Learn more and join us in Nashville: https://hubs.ly/Q04757ff0

A large-scale Medicare analysis is reshaping how clinicians and policymakers think about wound care product performance.

First-to-Podium research titled "Rethinking Regulatory Tiers: Medicare Real-World Evidence Shows Cellular, Acellular, and Matrix-Like Product (CAMP) Outcomes are Independent of FDA Regulatory Classification," presented today by William H. Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA, CWSP, at SAWC Spring | WHS, reveals that regulatory labels are not reliable indicators of real-world effectiveness.

- Evaluated over 3 million cases using longitudinal Medicare data
- Found no correlation between FDA classification and healing outcomes
- CAMP therapies consistently reduced mortality compared to standard care
- Demonstrated fewer amputations and lower complication rates
- Findings challenge reimbursement models based on regulatory tiering

Read more: https://hubs.ly/Q04b9CWP0

SAWC WOUNDS Wound Healing Society

A non-mammalian collagen source is emerging as a serious contender in advanced wound care.

In "Collagen Derived from the Barrel Jellyfish Demonstrates Efficacy as Next Generation Biomaterial for Wound Healing," Andrew Mearns Spragg, PhD, shared First-to-Podium data at SAWC Spring | WHS (underway now in Charlotte, NC), demonstrating how collagen type 0 (CT0) supports improved healing outcomes.

- Delivered regenerative outcomes that exceeded bovine collagen in preclinical evaluation
- Achieved significantly higher wound closure than film dressing controls
- Promoted re-epithelialization with a lower inflammatory profile
- Supported more complete granulation during the healing process
- Provides a biocompatible alternative without zoonotic disease risk

Read more: https://hubs.ly/Q04bblzx0

SAWC WOUNDS Wound Healing Society